Pfizer says that their COVID-19 vaccine booster could help protect against the Omicron variant.
-Pfizer and its partner BioNTech said lab tests showed a booster dose of their COVID-19 vaccine greatly increased the level of so-called neutralizing antibodies against omicron.
Scientists believe that the jump in antibodies that comes with a third dose of the vaccine might be enough to counter any decrease in effectiveness.
Pfizer announced the preliminary laboratory data in a press release and it hasn’t yet undergone scientific review. The companies already are working to create an omicron-specific vaccine in case it’s needed.
Pfizer CEO Albert Bourla said, “Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is maximized with a third dose of our vaccine.”
Pfizer’s announcement had an immediate impact on U.S. markets.
4/15/24 - Reaction After Iran Attacks Israel
4/15/24 - TAX Day - File By Midnight
4/5/24 - Preparations for the Eclipse are Well Underway
3/26/24 - A Major Bridge Collapse In Baltimore
3/20/24 - FBI & IRS Warn Of Illegal Charities, Donation Scams
3/15/24 - James Crumbley Also Found Guilty
3/15/24 - Air Fryer Recall
3/8/24 - FDA Warns Of Cinnamon Products Bought At Discount Stores
2/26/24 - AT&T Apologizes For Outage With $5 Credit
2/23/24 - Phone Outage Technical Error, Not Malicious Attack
2/22/24 - Numerous Cell Phone Service Providers Experience Outages
2/21/24 - More Student Loans To Be Forgiven
